Referring to studies of downstream targets regulated by METTL3 in tumours, it has been reported that in gastric cancer, METTL3 promotes ZMYM1 mRNA stability through m6A modification, subsequently enhancing its protein expression through the m6A reader protein HuR (also known as ELAVL1) [36]. The gene discussed is ELAVL1; the disease is gastric cancer.